Moderna’s hoped-for $8 bln IPO valuation
Moderna’s hoped-for $8 bln IPO valuation is a rich antidote to the funk hitting tech stocks. Rob Cyran explains that although the biotech firm’s technology is promising, it has no drugs near commercial readiness. That’s all the more reason to grab the money while it can.
from Reuters Video: Breakingviews https://ift.tt/2PchlUc
Hello, my name is Raja Saheb. I'm a 38 year old self-employed government from the Caribbean.
No comments:
Post a Comment